Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProBio: An Outcome-adaptive and Randomized Multi-arm Biomarker Driven Study in Patients With Metastatic Prostate Cancer

NCT03903835 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT03903835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03903835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProBio: An Outcome-adaptive and Randomized Multi-arm Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Lead sponsor
Karolinska Institutet
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2019
Completion date
December 31, 2026
Enrollment
750 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer (mcrpc), metastatic hormone-sensitive prostate cancer (mhspc)